Applied DNA Sciences (APDN) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Applied DNA Sciences Continues Its Successful Program Protecting Automobiles in Scandinavia
December 7, 2016 5:30 AM ESTSTONY BROOK, NY -- (Marketwired) -- 12/07/16 -- Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, is continuing its quest to protect automobiles in Scandinavia.
During fiscal 2016, Applied DNA realized revenues of approximately $500,000 from DNA marking of European luxury automobiles imported into Scandinavia. Revenue in fiscal 2017 is anticipated to increase, as more cars will be protected with its SmartDNA® product.
Working with insurers, Applied DNA conducted extensive pilots in... More
Applied DNA Sciences Reports Fiscal Fourth Quarter and Year End Results
December 6, 2016 4:05 PM ESTSTONY BROOK, NY -- (Marketwired) -- 12/06/16 -- Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced financial results for the full fiscal year and quarter ended September 30, 2016.
Commenting on Applied DNA's performance for the fiscal year, Dr. James A. Hayward, president and chief executive officer, stated, "Fiscal 2016 stands out for the growing maturation of three key verticals - textiles, government/defense and pharmaceuticals - reflecting our efforts to build demand combined with favorable industry... More
